Anti-Proliferative and Pro-Apoptotic Effects of (-)-Epigallocatechin-3- Gallate Encapsulated in Chitosan Nanoparticles on Human Prostate Carcinoma Cells
Journal Title: Journal of Pharmaceutics & Pharmacology - Year 2014, Vol 2, Issue 1
Abstract
(-)-epigallocatechin-3-gallate (EGCG), the major polyphenol of green tea, has shown excellent effects in preventing, as well as treating, many cancers including prostate cancer (PCa) in preclinical model systems. However its applicability to humans has met with limited success due to several issues including its limited bioavailability. We employed the use of nanotechnology to improve the outcome of cancer chemoprevention and coined the concept ‘nanochemoprevention’. Recently, we reported the synthesis, characterization and efficacy assessment of a formulation of chitosan encapsulating EGCG (Chit-nanoEGCG) for treatment of PCa in a xenograft model [1]. Here we show the efficacy of this nanoformulation in human PCa cells for inhibition of cell growth, induction of apoptosis, and inhibition of the colony formation. We further demonstrate that the encapsulated EGCG retains its mechanistic identity for induction of apoptosis. We observed that chit- nanoEGCG treatment induces apoptosis and also results in growth arrest of the cells in S phase and the cell cycle-regulatory molecules operative in the G1/S phase of the cell cycle were significantly modulated. All these effects were seen at much lower doses in chit-nanoEGCG treated cells as compared to the native agent. Collectively, chit- nanoEGCG could prove useful for preventing and/or treating human PCa.
Authors and Affiliations
Hasan Mukhtar
Keywords
Related Articles
- EP ID EP197912
- DOI 10.13188/2327-204X.1000007
- Views 106
- Downloads 0
Targeting the Endocannabinoid System for Neuroprotection: A 19F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA
Fatty acid amide hydrolase (FAAH), the enzyme involved in the inactivation of the endocannabinoid anandamide (AEA), is being considered as a therapeutic target for analgesia and neuroprotection. We have developed a brain...
Current Medication Trends and Global Impact on Neurodegenerative Disorders
Neurodegenerative disorders are the medical condition characterized by destruction in neuronal cells, abruption of neuronal activity and distinct involvement of the functional movement. The main neuronal disorders like P...
The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain
Neuroinflammation is a crucial mechanism related to many neurological diseases. Extensive studies in recent years have indicated that dysregulation of Glycogen Synthase Kinase 3 Beta (GSK3β) contributes to the developmen...
An Alternative Therapeutic Approach on Bone Cells Differentiation after Administration of Biofield Energy Treated Vitamin D3 in MG-63 Cell line
The objective of the current experiment was to evaluate the potential of Consciousness Energy Healing-based test items (Vitamin D3 and DMEM) on bone parameters. Both the TI were distributed into two individual parts. One...
Invitro and Invivo Inhibition of Metyrapone metabolism by Glycyrrhetinic Acid in Male Wistar Rats
Objectives: We investigated the inhibitory effect of glycyrrhetinic acid (GA), an 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor, on the reductive metabolism of metyrapone (MP) in an invitro study, and the...